We believe that the 11 genes, especially CARD6, NLRP2, OBSCN, and USP40, could be used as useful diagnostic, prognostic, and therapeutic markers in ccRCC. This evidence concerns the gene NLRP2 and nonpapillary renal cell carcinoma.